LKT Labs

Biochemicals for Life Science Research

Awaiting product image

Snake venom – Crotalus durissus terrificus

Product ID SC7056
Cas No.
Purity ≥98%
Product Unit SizeCostQuantityStock
100 mg $210.00 In stock
Bulk Quote

Quicklinks

Description

This product is a snake venom found in Crotalus durrisus terrificus including several toxins that cause myalgia, muscle weakness, and rhabdomyolysis. Crotoxin acts on N-type and P/Q-type Ca2+ channels to induce glutamate release and crotamine induces acetylcholine (ACh) and DA release. Crotoxin also potentiates activity at L-type Ca2+ channels. Gyrotoxin is a serine protease with thrombin-like activity. Together, these toxins may induce paralysis, acting as a neuromuscular junction (NMJ) blocker.

Product Info

Purity

≥98%
Appearance

Yellow Crystalline Solid

Shipping and Storage

Store Temp

4°C
Ship Temp

Ambient

Downloads

MSDS

SC7056 MSDS PDF
Info Sheet

SC7056 Info Sheet PDF

References

Bucaretchi F, De Capitani EM, Hyslop S, et al. Compartment syndrome after South American rattlesnake (Crotalus durissus terrificus) envenomation. Clin Toxicol (Phila). 2014 Jul;52(6):639-41. PMID: 24940645.

Vargas LS, Lara MV, Gonçalves R, et al. The intrahippocampal infusion of crotamine from Crotalus durissus terrificus venom enhances memory persistence in rats. Toxicon. 2014 Jul;85:52-8. PMID: 24813333.

Lomeo Rda S, Gonçalves AP, Silva CN, et al. Crotoxin from Crotalus durissus terrificus snake venom induces the release of glutamate from cerebrocortical synaptosomes via N and P/Q calcium channels. Toxicon. 2014 Jul;85:5-16. PMID: 24751366.

Yonamine CM, Kondo MY, Nering MB, et al. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors. Toxicon. 2014 Mar;79:64-71. PMID: 24412460.

Ribeiro Gde B, Almeida HC, Velarde DT, et al. Study of crotoxin on the induction of paralysis in extraocular muscle in animal model. Arq Bras Oftalmol. 2012 Oct;75(5):307-12. PMID: 23471322.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • N800000

    NU-2058

    CDK1/2 inhibitor.

    ≥98%
  • C9673

    Cysteamine Hydrochloride

    Aminothiol, CoA component; ulcer inducer.

    ≥99%
  • T5611

    δ-Tocotrienol

    Antioxidant, vitamin E derivative found in vege...

    ≥98%
  • F4682

    Fluconazole

    Triazole; 14-α demethylase inhibitor.

    ≥98%
  • E5219

    Endothelin-1, human

    Endogenous peptide involved in vascular contrac...

    ≥95%
  • C0375

    Ac-DEVD-pNA

    Caspase 3 substrate.

    ≥95%
  • S0253

    Sanguinarine

    Benzophenanthridine alkaloid found in various p...

    ≥98%
  • L8261

    Lupeol

    Triterpene; potential tyrosinase inhibitor.

    ≥98%
  • C2800

    Chalcone

    Enone.

    ≥97%
  • D336486

    Dimethylamino Parthenolide

    Water-soluble parthenolide analog; NF-κB inhib...

    ≥98%
  • A121008

    Adagrasib

    KRAS inhibitor

    ≥99%
  • C0149

    Calcitonin, salmon

    Endogenous neuropeptide hormone, lowers extrace...

    ≥98%
  • C4532

    Clindamycin Hydrochloride

    Lincosamide; ribosomal translocation and protei...

    ≥98%
  • P200099

    PF-06939999

    PRMT5 inhibitor

    ≥98%
  • L1981

    Leucokinin VIII

    Peptide found in insects.

    ≥95%
  • S8169

    Suramin Hexasodium

    RyR agonist, SIRT, telomerase, P2Y, GPCR inhibi...

    ≥98%
  • A4933

    Amifostine Trihydrate

    Thiol prodrug, antioxidant.

    ≥98%
  • A5282

    [Sar1 Ile8]-Angiotensin II

    Peptide, derivative of AT II, involved in vasoc...

    ≥95%
  • C0396

    CAY10505

    p110γ PI3K inhibitor.

    ≥98%
  • P0369

    Parecoxib Sodium

    NSAID; COX-2 inhibitor.

    ≥99%